Fig. 2
From: Patient-reported outcome measures for retinoblastoma: a scoping review
PROM identification and breakdown, flow diagram. Of the PROMs identified for use in the populations of interest (n = 143), validation articles (n = 100) and were subsequently were identified for pediatric ophthalmology (PedOphth) and pediatric oncology (PedOnc) PROMs. PROMs were then assessed by the COSMIN good measurement property checklist for methodologic quality